What is the added value of TBS in osteoporosis clinical management?

May is Osteoporosis Awareness Month, dedicated to raising awareness about this silent chronic disease affecting 1 in 3 women and 1 in 5 men over the age of 50.

Osteoporosis is a systemic skeletal disease characterized by diminished bone mass and the degradation of bone microarchitecture. These dual components — bone mass and bone microarchitecture — underpin the structural integrity necessary for bone resilience against fractures .

Diagnosis of osteoporosis is traditionally centered around bone mineral density (BMD). Yet, most of fractures occur in patients with T-scores outside the osteoporotic range¹. Integrating bone microarchitecture into the assessment framework is requisite to refine the identification of those at increased fracture risk. This can be achieved with Trabecular Bone Score (TBS). TBS provides extremely useful additional clinical information as to the microarchitecture of the bone.

What is the added value of TBS in osteoporosis clinical management? ​Download the whitepaper below.

¹Didier Hans, Andrew L Goertzen, Marc‐Antoine Krieg, William D Leslie, Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study, Journal of Bone and Mineral Research, Volume 26, Issue 11, 1 November 2011, Pages 2762–2769